Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds. 

Biotechnology

Life Sciences

Therapeutics

Graviton Bioscience

Graviton Bioscience's headquarters in New York, United States

Samuel Waksal

Fujiko Otofuji

Suacer M. Tejeda

Rui Wu

Christie Matsui

Alexandra Zanin-Zhorov

Amy Melsaether

The Clinical Operations Team at Graviton Bioscience is responsible for overseeing the planning, execution, and management of clinical trials for therapies targeting ROCK2 and other therapeutic compounds. This team ensures that trials are conducted efficiently, compliantly, and in alignment with strategic company goals, thereby facilitating the advancement of Graviton's clinical-stage biotechnology projects.

Clinical Operations Team

This department focuses on advancing scientific knowledge and developing innovative solutions through research and experimentation.

Research and Development

This department focuses on the advancement of clinical research and the development of new medical treatments.

Clinical Development

This department oversees the planning, execution, and management of clinical trials and ensures compliance with regulatory standards.

Clinical Operations

This department oversees medical and regulatory compliance, ensuring product safety and efficacy throughout the supply chain.

Medical Affairs

This department oversees the operational processes and strategies to enhance efficiency and effectiveness within the organization.

Graviton Bioscience

Org chart

Teams

Clinical Operations Team

Research and Development

Clinical Development

Clinical Operations

Medical Affairs

Operations Management

Offices

Graviton Bioscience

Org chart

Teams

Clinical Operations Team

Research and Development

Clinical Development

Clinical Operations

Medical Affairs

Operations Management

Offices

Related companies